- Home
- PSQH vs LUNG Comparison
PSQH vs LUNG Comparison
Compare PSQH & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSQH
- LUNG
- Stock Information
- Founded
- PSQH 2021
- LUNG 1995
- Country
- PSQH United States
- LUNG United States
- Employees
- PSQH N/A
- LUNG N/A
- Industry
- PSQH Advertising
- LUNG Industrial Specialties
- Sector
- PSQH Consumer Discretionary
- LUNG Health Care
- Exchange
- PSQH Nasdaq
- LUNG Nasdaq
- Market Cap
- PSQH 73.1M
- LUNG 63.6M
- IPO Year
- PSQH N/A
- LUNG 2020
- Fundamental
- Price
- PSQH $1.57
- LUNG $1.52
- Analyst Decision
- PSQH Strong Buy
- LUNG Buy
- Analyst Count
- PSQH 2
- LUNG 7
- Target Price
- PSQH $6.00
- LUNG $6.81
- AVG Volume (30 Days)
- PSQH 789.8K
- LUNG 6.9M
- Earning Date
- PSQH 11-06-2025
- LUNG 11-12-2025
- Dividend Yield
- PSQH N/A
- LUNG N/A
- EPS Growth
- PSQH N/A
- LUNG N/A
- EPS
- PSQH N/A
- LUNG N/A
- Revenue
- PSQH $27,534,522.00
- LUNG $91,664,000.00
- Revenue This Year
- PSQH N/A
- LUNG $10.41
- Revenue Next Year
- PSQH $49.92
- LUNG $10.98
- P/E Ratio
- PSQH N/A
- LUNG N/A
- Revenue Growth
- PSQH 46.94
- LUNG 15.59
- 52 Week Low
- PSQH $1.55
- LUNG $1.47
- 52 Week High
- PSQH $7.77
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- PSQH 33.53
- LUNG 41.72
- Support Level
- PSQH $1.67
- LUNG $1.65
- Resistance Level
- PSQH $1.95
- LUNG $2.11
- Average True Range (ATR)
- PSQH 0.11
- LUNG 0.25
- MACD
- PSQH -0.04
- LUNG -0.02
- Stochastic Oscillator
- PSQH 0.74
- LUNG 2.47
About PSQH PSQ Holdings Inc.
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.